Showing results (1161-1170 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|December 10, 2014
DPP-4 inhibitors: focus on safetySri Harsha Tella, Marc S RendellExpert Opinion on Drug Safety|December 10, 2014
Systemic safety of anti-VEGF drugs: a commentaryLauren J Scott, Usha Chakravarthy, Barnaby C Reeves, et al.Expert Opinion on Drug Safety|December 11, 2014
Cardiac risks associated with antibiotics: azithromycin and levofloxacinZhiqiang Kevin Lu, Jing Yuan, Minghui Li, et al.Expert Opinion on Drug Safety|October 2, 2014
Safety of antiandrogen therapy for treating prostate cancerFrancesco Ricci, Giulia Buzzatti, Alessandra Rubagotti, et al.Expert Opinion on Drug Safety|September 23, 2015
Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting systemRasha M Arabyat, Dennis W Raisch, June M McKoy, et al.Expert Opinion on Drug Safety|September 24, 2015
Risk-adapted strategies for the treatment of Hodgkin lymphomaJesse Keller, Kenneth R CarsonExpert Opinion on Drug Safety|September 25, 2015
The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary diseaseD P TashkinExpert Opinion on Drug Safety|October 3, 2015
The safety of treatments for angioedema with hereditary C1 inhibitor deficiencyAndrea Zanichelli, Maddalena Alessandra Wu, Arnaldo Andreoli, et al.Expert Opinion on Drug Safety|October 6, 2015
The safety of liposome bupivacaine 2 years post-launch: a look back and a look forwardEugene R ViscusiExpert Opinion on Drug Safety|October 21, 2015
Drug safety evaluation of lenvatinib for thyroid cancerJolanta Krajewska, Aleksandra Kukulska, Barbara JarzabPageof 282